Dnmt3b prefers germ line genes and centromeric regions: Lessons from the ICF syndrome and cancer and implications for diseases

Biology

Volumn 3, Issue 3, 2014, Pages 578-605

  Walton, Emma L ^a   Francastel, Claire ^a   Velasco, Guillaume ^a  

^a Université Sorbonne Paris Cité   (France)

Author keywords

Cancer; Centromeric repeats; DNA methylation; DNMT3B; Germ line genes; ICF syndrome

Indexed keywords

EID: 84907555949     PISSN: None     EISSN: 20797737     Source Type: Journal    
DOI: 10.3390/biology3030578     Document Type: Article

References (153)

1. Jones, P.A.; Taylor, S.M.; Wilson, V. DNA modification, differentiation, and transformation. J. Exp. Zool. 1983, 228, 287–295.
2. Meissner, A.; Mikkelsen, T.S.; Gu, H.; Wernig, M.; Hanna, J.; Sivachenko, A.; Zhang, X.; Bernstein, B.E.; Nusbaum, C.; Jaffe, D.B.; et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2010, 454, 766–770.
3. Weber, M.; Hellmann, I.; Stadler, M.B.; Ramos, L.; Paabo, S.; Rebhan, M.; Schubeler, D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 2007, 39, 457-466.
4. Weber, M.; Schubeler, D. Genomic patterns of DNA methylation: Targets and function of an epigenetic mark. Curr. Opin. Cell Biol. 2007, 19, 273-280.
5. Illingworth, R.; Kerr, A.; Desousa, D.; Jorgensen, H.; Ellis, P.; Stalker, J.; Jackson, D.; Clee, C; Plumb, R.; Rogers, J.; et al. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 2008, 6, e22.
6. Razin, A.; Cedar, H. DNA methylation and gene expression. Microbiol. Rev. 1991, 55, 451-458.
7. Bird, A.P.; Wolffe, A.P. Methylation-induced repression—Belts, braces, and chromatin. Cell 1999, 99, 451-454.
8. Shukla, S.; Kavak, E.; Gregory, M.; Imashimizu, M.; Shutinoski, B.; Kashlev, M.; Oberdoerffer, P.; Sandberg, R.; Oberdoerffer, S. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011, 479, 74-79.
9. Maunakea, A.K.; Nagarajan, R.P.; Bilenky, M.; Ballinger, T.J.; D'Souza, C; Fouse, S.D.; Johnson, B.E.; Hong, C; Nielsen, C; Zhao, Y.; et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466, 253-257.
10. Li, E.; Bestor, T.H.; Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69, 915-926.
11. Walsh, C.P.; Chaillet, J.R.; Bestor, T.H. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat. Genet. 1998, 20, 116-117.
12. Sasaki, H.; Jones, PA.; Chaillet, J.R.; Ferguson-Smith, A.C.; Barton, S.C.; Reik, W.; Surani, MA. Parental imprinting: Potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (IGF2) gene. Genes Dev. 1992, 6, 1843-1856.
13. Li, E.; Beard, C; Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 1993, 366, 362-365.
14. Panning, B.; Jaenisch, R. DNA hypomethylation can activate Xist expression and silence X-linked genes. Genes Dev. 1996, 10, 1991-2002.
15. Okano, M.; Xie, S.; Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 1998, 19, 219-220.
16. Bostick, M.; Kim, J.K.; Esteve, P.O.; Clark, A.; Pradhan, S.; Jacobsen, S.E. Uhrf1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317, 1760-1764.
17. Hermann, A.; Goyal, R.; Jeltsch, A. The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J. Biol. Chem. 2004, 279, 48350-48359.
18. Chedin, F.; Lieber, M.R.; Hsieh, C.L. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc. Natl. Acad. Sci. USA 2002, 99, 16916-16921.
19. Guenatri, M.; Duffie, R.; Iranzo, J.; Fauque, P.; Bourc’his, D. Plasticity in Dnmt3L-dependent and -independent modes of de novo methylation in the developing mouse embryo. Development 2013, 140, 562-572.
20. Okano, M.; Bell, D.W.; Haber, DA.; Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99, 247-257.
21. Liang, G.; Chan, M.F.; Tomigahara, Y.; Tsai, Y.C.; Gonzales, F.A.; Li, E.; Laird, P.W.; Jones, P.A. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell Biol. 2002, 22, 480–491.
22. Chen, T.; Ueda, Y.; Dodge, J.E.; Wang, Z.; Li, E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 2003, 23, 5594–5605.
23. Walton, E.L.; Francastel, C.; Velasco, G. Maintenance of DNA methylation: Dnmt3b joins the dance. Epigenetics 2011, 6, 1373–1377.
24. Chen, T.; Tsujimoto, N.; Li, E. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin. Mol. Cell Biol. 2004, 24, 9048–9058.
25. Bachman, K.E.; Rountree, M.R.; Baylin, S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 2001, 276, 32282–32287.
26. Zhang, Y.; Jurkowska, R.; Soeroes, S.; Rajavelu, A.; Dhayalan, A.; Bock, I.; Rathert, P.; Brandt, O.; Reinhardt, R.; Fischle, W.; et al. Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the add domain with the histone H3 tail. Nucl. Acids Res. 2010, 38, 4246–4253.
27. Gordon, C.A.; Hartono, S.R.; Chedin, F. Inactive DNMT3B splice variants modulate de novo DNA methylation. PLoS One 2013, 8, e69486.
28. Gopalakrishnan, S.; van Emburgh, B.O.; Shan, J.; Su, Z.; Fields, C.R.; Vieweg, J.; Hamazaki, T.; Schwartz, P.H.; Terada, N.; Robertson, K.D. A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding. Mol. Cancer Res. 2009, 7, 1622–1634.
29. Ostler, K.R.; Davis, E.M.; Payne, S.L.; Gosalia, B.B.; Exposito-Cespedes, J.; le Beau, M.M.; Godley, L.A. Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene 2007, 26, 5553–5563.
30. Saito, Y.; Kanai, Y.; Sakamoto, M.; Saito, H.; Ishii, H.; Hirohashi, S. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3B4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA 2002, 99, 10060–10065.
31. Wang, L.; Wang, J.; Sun, S.; Rodriguez, M.; Yue, P.; Jang, S.J.; Mao, L. A novel DNMT3B subfamily, deltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. Int. J. Oncol. 2008, 29, 201–207.
32. Weisenberger, D.J.; Velicescu, M.; Cheng, J.C.; Gonzales, F.A.; Liang, G.; Jones, P.A. Role of the DNA methyltransferase variant Dnmt3b3 in DNA methylation. Mol. Cancer Res. 2004, 2, 62–72.
33. Weisenberger, D.J.; Velicescu, M.; Preciado-Lopez, M.A.; Gonzales, F.A.; Tsai, Y.C.; Liang, G.; Jones, P.A. Identification and characterization of alternatively spliced variants of DNA methyltransferase 3a in mammalian cells. Gene 2002, 298, 91–99.
34. Huntriss, J.; Hinkins, M.; Oliver, B.; Harris, S.E.; Beazley, J.C.; Rutherford, A.J.; Gosden, R.G.; Lanzendorf, S.E.; Picton, H.M. Expression of mRNAs for DNA methyltransferases and methyl-CpG-binding proteins in the human female germ line, preimplantation embryos, and embryonic stem cells. Mol. Reprod. Dev. 2004, 67, 323–336.
35. Robertson, K.D.; Uzvolgyi, E.; Liang, G.; Talmadge, C.; Sumegi, J.; Gonzales, F.A.; Jones, P.A. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucl. Acids Res. 1999, 27, 2291–2298.
36. Xu, G.L.; Bestor, T.H.; Bourc’his, D.; Hsieh, C.L.; Tommerup, N.; Bugge, M.; Hulten, M.; Qu, X.; Russo, J.J.; Viegas-Pequignot, E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999, 402, 187–191.
37. Guenatri, M.; Bailly, D.; Maison, C.; Almouzni, G. Mouse centric and pericentric satellite repeats form distinct functional heterochromatin. J. Cell. Biol. 2004, 166, 493–505.
38. Yamagishi, Y.; Sakuno, T.; Shimura, M.; Watanabe, Y. Heterochromatin links to centromeric protection by recruiting shugoshin. Nature 2008, 455, 251–255.
39. Choo, K.H. The Centromere; Oxford University Press Inc.: New York, NY, USA, 1997.
40. Martens, J.H.; O’Sullivan, R.J.; Braunschweig, U.; Opravil, S.; Radolf, M.; Steinlein, P.; Jenuwein, T. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 2005, 24, 800–812.
41. Vourc’h, C.; Biamonti, G. Transcription of satellite DNAs in mammals. Prog. Mol. Subcell. Biol. 2011, 51, 95–118.
42. Choo, K.H. Domain organization at the centromere and neocentromere. Dev. Cell. 2001, 1, 165–177.
43. Earnshaw, W.C.; Cooke, C.A. Proteins of the inner and outer centromere of mitotic chromosomes. Genome 1989, 31, 541–552.
44. Eymery, A.; Callanan, M.; Vourc’h, C. The secret message of heterochromatin: New insights into the mechanisms and function of centromeric and pericentric repeat sequence transcription. Int. J. Dev. Biol. 2009, 53, 259–268.
45. Hall, L.E.; Mitchell, S.E.; O’Neill, R.J. Pericentric and centromeric transcription: A perfect balance required. Chromosom. Res. 2012, 20, 535–546.
46. Bouzinba-Segard, H.; Guais, A.; Francastel, C. Accumulation of small murine minor satellite transcripts leads to impaired centromeric architecture and function. Proc. Natl. Acad. Sci. USA 2006, 103, 8709–8714.
47. Ferri, F.; Bouzinba-Segard, H.; Velasco, G.; Hubé, F.; Francastel, C. Non-coding murine centromeric transcripts associate with and potentiate Aurora B kinase. Nucl. Acids Res. 2009, 37, 5071–5080.
48. Probst, A.V.; Okamoto, I.; Casanova, M.; El Marjou, F.; Le Baccon, P.; Almouzni, G. A strand-specific burst in transcription of pericentric satellites is required for chromocenter formation and early mouse development. Dev. Cell. 2010, 19, 625–638.
49. Borgel, J.; Guibert, S.; Li, Y.; Chiba, H.; Schubeler, D.; Sasaki, H.; Forne, T.; Weber, M. Targets and dynamics of promoter DNA methylation during early mouse development. Nat. Genet. 2010, 42, 1093–1100.
50. Velasco, G.; Hube, F.; Rollin, J.; Neuillet, D.; Philippe, C.; Bouzinba-Segard, H.; Galvani, A.; Viegas-Pequignot, E.; Francastel, C. Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues. Proc. Natl. Acad. Sci. USA 2010, 107, 9281–9286.
51. De Smet, C.; Lurquin, C.; Lethe, B.; Martelange, V.; Boon, T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 1999, 19, 7327–7335.
52. Maatouk, D.M.; Kellam, L.D.; Mann, M.R.; Lei, H.; Li, E.; Bartolomei, M.S.; Resnick, J.L. DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development 2006, 133, 3411–3418.
53. Hackett, J.A.; Reddington, J.P.; Nestor, C.E.; Dunican, D.S.; Branco, M.R.; Reichmann, J.; Reik, W.; Surani, M.A.; Adams, I.R.; Meehan, R.R. Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline. Development 2012, 139, 3623–3632.
54. Tsien, F.; Sun, B.; Hopkins, N.E.; Vedanarayanan, V.; Figlewicz, D.; Winokur, S.; Ehrlich, M. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues. Mol. Genet. Metab. 2001, 74, 322–331.
55. Nishiyama, R.; Qi, L.; Tsumagari, K.; Weissbecker, K.; Dubeau, L.; Champagne, M.; Sikka, S.; Nagai, H.; Ehrlich, M. A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others. Cancer Biol. Ther. 2005, 4, 440–448.
56. Kondo, T.; Bobek, M.P.; Kuick, R.; Lamb, B.; Zhu, X.; Narayan, A.; Bourc’his, D.; Viegas-Pequignot, E.; Ehrlich, M.; Hanash, S.M. Whole-genome methylation scan in ICF syndrome: Hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum. Mol. Genet. 2000, 9, 597–604.
57. Miniou, P.; Bourc’his, D.; Molina Gomes, D.; Jeanpierre, M.; Viegas-Pequignot, E. Undermethylation of Alu sequences in ICF syndrome: Molecular and in situ analysis. Cytogenet. Cell. Genet. 1997, 77, 308–313.
58. Yehezkel, S.; Segev, Y.; Viegas-Pequignot, E.; Skorecki, K.; Selig, S. Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum. Mol. Genet. 2008, 17, 2776–2789.
59. Brock, G.J.; Charlton, J.; Bird, A. Densely methylated sequences that are preferentially localized at telomere-proximal regions of human chromosomes. Gene 1999, 240, 269–277.
60. Craig, J.M.; Earle, E.; Canham, P.; Wong, L.H.; Anderson, M.; Choo, K.H. Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns. Hum. Mol. Genet. 2003, 12, 3109–3121.
61. Ueda, Y.; Okano, M.; Williams, C.; Chen, T.; Georgopoulos, K.; Li, E. Roles for Dnmt3b in mammalian development: A mouse model for the ICF syndrome. Development 2006, 133, 1183–1192.
62. Marks, H.; Kalkan, T.; Menafra, R.; Denissov, S.; Jones, K.; Hofemeister, H.; Nichols, J.; Kranz, A.; Stewart, A.F.; Smith, A.; et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell. 2012, 149, 590–604.
63. Kriaucionis, S.; Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in purkinje neurons and the brain. Science 2009, 324, 929–930.
64. Tahiliani, M.; Koh, K.P.; Shen, Y.; Pastor, W.A.; Bandukwala, H.; Brudno, Y.; Agarwal, S.; Iyer, L.M.; Liu, D.R.; Aravind, L.; et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324, 930–935.
65. Seisenberger, S.; Peat, J.R.; Hore, T.A.; Santos, F.; Dean, W.; Reik, W. Reprogramming DNA methylation in the mammalian life cycle: Building and breaking epigenetic barriers. Philos. Trans. R Soc. Lond. B Biol. Sci. 2013, 368, 20110330.
66. Guibert, S.; Weber, M. Functions of DNA methylation and hydroxymethylation in mammalian development. Curr. Top. Dev. Biol. 2013, 104, 47–83.
67. Sakaue, M.; Ohta, H.; Kumaki, Y.; Oda, M.; Sakaide, Y.; Matsuoka, C.; Yamagiwa, A.; Niwa, H.; Wakayama, T.; Okano, M. DNA methylation is dispensable for the growth and survival of the extraembryonic lineages. Curr. Biol. 2010, 20, 1452–1457.
68. Tsumura, A.; Hayakawa, T.; Kumaki, Y.; Takebayashi, S.; Sakaue, M.; Matsuoka, C.; Shimotohno, K.; Ishikawa, F.; Li, E.; Ueda, H.R.; et al. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 2006, 11, 805–814.
69. Jackson-Grusby, L.; Beard, C.; Possemato, R.; Tudor, M.; Fambrough, D.; Csankovszki, G.; Dausman, J.; Lee, P.; Wilson, C.; Lander, E.; et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet. 2001, 27, 31–39.
70. Senner, C.E.; Krueger, F.; Oxley, D.; Andrews, S.; Hemberger, M. DNA methylation profiles define stem cell identity and reveal a tight embryonic-extraembryonic lineage boundary. Stem Cells 2012, 30, 2732–2745.
71. Veillard, A.C.; Marks, H.; Bernardo, A.S.; Jouneau, L.; Laloe, D.; Boulanger, L.; Kaan, A.; Brochard, V.; Tosolini, M.; Pedersen, R.; et al. Stable methylation at promoters distinguishes epiblast stem cells from embryonic stem cells and the in vivo epiblast. Stem Cells Dev. 2014, 23, 2014–2029.
72. Habibi, E.; Brinkman, A.B.; Arand, J.; Kroeze, L.I.; Kerstens, H.H.; Matarese, F.; Lepikhov, K.; Gut, M.; Brun-Heath, I.; Hubner, N.C.; et al. Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell. Stem Cell. 2013, 13, 360–369.
73. Leitch, H.G.; McEwen, K.R.; Turp, A.; Encheva, V.; Carroll, T.; Grabole, N.; Mansfield, W.; Nashun, B.; Knezovich, J.G.; Smith, A.; et al. Naive pluripotency is associated with global DNA hypomethylation. Nat. Struct. Mol. Biol. 2013, 20, 311–316.
74. Arand, J.; Spieler, D.; Karius, T.; Branco, M.R.; Meilinger, D.; Meissner, A.; Jenuwein, T.; Xu, G.; Leonhardt, H.; Wolf, V.; et al. In vivo control of CpG and non- CpG DNA methylation by DNA methyltransferases. PLoS Genet 2012, 8, e1002750.
75. Zvetkova, I.; Apedaile, A.; Ramsahoye, B.; Mermoud, J.E.; Crompton, L.A.; John, R.; Feil, R.; Brockdorff, N. Global hypomethylation of the genome in XX embryonic stem cells. Nat. Genet. 2005, 37, 1274–1279.
76. Grabole, N.; Tischler, J.; Hackett, J.A.; Kim, S.; Tang, F.; Leitch, H.G.; Magnusdottir, E.; Surani, M.A. Prdm14 promotes germline fate and naive pluripotency by repressing FGF signalling and DNA methylation. EMBO Rep. 2013, 14, 629–637.
77. Guibert, S.; Forne, T.; Weber, M. Global profiling of DNA methylation erasure in mouse primordial germ cells. Genome Res. 2012, 22, 633–641.
78. Hajkova, P.; Erhardt, S.; Lane, N.; Haaf, T.; El-Maarri, O.; Reik, W.; Walter, J.; Surani, M.A. Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 2002, 117, 15–23.
79. Lees-Murdock, D.J.; de Felici, M.; Walsh, C.P. Methylation dynamics of repetitive DNA elements in the mouse germ cell lineage. Genomics 2003, 82, 230–237.
80. La Salle, S.; Mertineit, C.; Taketo, T.; Moens, P.B.; Bestor, T.H.; Trasler, J.M. Windows for sex-specific methylation marked by DNA methyltransferase expression profiles in mouse germ cells. Dev. Biol. 2004, 268, 403–415.
81. Yamagata, K.; Yamazaki, T.; Miki, H.; Ogonuki, N.; Inoue, K.; Ogura, A.; Baba, T. Centromeric DNA hypomethylation as an epigenetic signature discriminates between germ and somatic cell lineages. Dev. Biol. 2007, 312, 419–426.
82. Riggs, A.D.; Xiong, Z. Methylation and epigenetic fidelity. Proc. Natl. Acad. Sci. USA 2004, 101, 4–5.
83. Brandeis, M.; Frank, D.; Keshet, I.; SIegfried, Z.; Mendelsohn, M.; Nemes, A.; Temper, V.; Razin, A.; Cedar, H. Sp1 elements protect a CpG island from de novo methylation. Nature 1994, 371, 435–438.
84. Macleod, D.; Charlton, J.; Cullins, J.; Bird, A.P. Sp1 sites in the mouse Aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 1994, 8, 2282–2292.
85. Lienert, F.; Wirbelauer, C.; Som, I.; Dean, A.; Mohn, F.; Schubeler, D. Identification of genetic elements that autonomously determine DNA methylation states. Nat. Genet. 2011, 43, 1091–1097.
86. Wienholz, B.L.; Kareta, M.S.; Moarefi, A.H.; Gordon, C.A.; Ginno, P.A.; Chedin, F. Dnmt3L modulates significant and distinct flanking sequence preference for DNA methylation by Dnmt3a and Dnmt3b in vivo. PLoS Genet. 2010, 6, 1001106.
87. Hervouet, E.; Vallette, F.M.; Cartron, P.F. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics 2009, 4, 487–499.
88. Maeda, I.; Okamura, D.; Tokitake, Y.; Ikeda, M.; Kawaguchi, H.; Mise, N.; Abe, K.; Noce, T.; Okuda, A.; Matsui, Y. Max is a repressor of germ cell-related gene expression in mouse embryonic stem cells. Nat. Commun. 2013, 4, 1754.
89. Gopalakrishnan, S.; Sullivan, B.A.; Trazzi, S.; Della Valle, G.; Robertson, K.D. DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions. Hum. Mol. Genet. 2009, 18, 3178–3193.
90. Dennis, K.; Fan, T.; Geiman, T.; Yan, Q.; Muegge, K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev. 2001, 15, 2940–2944.
91. Geiman, T.M.; Tessarollo, L.; Anver, M.R.; Kopp, J.B.; Ward, J.M.; Muegge, K. Lsh, a SNF2 family member, is required for normal murine development. Biochim. Biophys. Acta 2001, 1526, 211–220.
92. Huang, J.; Fan, T.; Yan, Q.; Zhu, H.; Fox, S.; Issaq, H.J.; Best, L.; Gangi, L.; Munroe, D.; Muegge, K. Lsh, an epigenetic guardian of repetitive elements. Nucl. Acids Res. 2004, 32, 5019–5028.
93. Myant, K.; Termanis, A.; Sundaram, A.Y.; Boe, T.; Li, C.; Merusi, C.; Burrage, J.; de Las Heras, J.I.; Stancheva, I. Lsh and G9a/GLP complex are required for developmentally programmed DNA methylation. Genome Res. 2011, 21, 83–94.
94. Tao, Y.; Xi, S.; Shan, J.; Maunakea, A.; Che, A.; Briones, V.; Lee, E.Y.; Geiman, T.; Huang, J.; Stephens, R.; et al. Lsh, chromatin remodeling family member, modulates genome-wide cytosine methylation patterns at nonrepeat sequences. Proc. Natl. Acad. Sci. USA 2011, 108, 5626–5631.
95. Xi, S.; Geiman, T.M.; Briones, V.; Guang Tao, Y.; Xu, H.; Muegge, K. Lsh participates in DNA methylation and silencing of stem cell genes. Stem Cells 2009, 27, 2691–2702.
96. Dunican, D.S.; Cruickshanks, H.A.; Suzuki, M.; Semple, C.A.; Davey, T.; Arceci, R.J.; Greally, J.; Adams, I.R.; Meehan, R.R. Lsh regulates LTR retrotransposon repression independently of Dnmt3b function. Genome Biol. 2013, 14, R146.
97. Myant, K.; Stancheva, I. Lsh cooperates with DNA methyltransferases to repress transcription. Mol. Cell. Biol. 2008, 28, 215–226.
98. Aravin, A.A.; Sachidanandam, R.; Girard, A.; Fejes-Toth, K.; Hannon, G.J. Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 2007, 316, 744–747.
99. Schmitz, K.M.; Mayer, C.; Postepska, A.; Grummt, I. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of Dnmt3b and silencing of rRNA genes. Genes Dev. 2010, 24, 2264–2269.
100. Volpe, T.A.; Kidner, C.; Hall, I.M.; Teng, G.; Grewal, S.I.; Martienssen, R.A. Regulation of heterochromatic silencing and histone h3 lysine-9 methylation by RNAi. Science 2002, 297, 1833–1837.
101. Scarano, M.I.; Strazzullo, M.; Matarazzo, M.R.; D’Esposito, M. DNA methylation 40 years later: Its role in human health and disease. J. Cell. Physiol. 2005, 204, 21–35.
102. Wilson, A.S.; Power, B.E.; Molloy, P.L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta. 2007, 1775, 138–162.
103. Robertson, K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6, 597–610.
104. Gronbaek, K.; Hother, C.; Jones, P.A. Epigenetic changes in cancer. APMIS 2007, 115, 1039–1059.
105. Feinberg, A.P.; Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301, 89–92.
106. Ehrlich, M. DNA hypomethylation in cancer cells. Epigenomics 2009, 1, 239–259.
107. Feinberg, A.P.; Vogelstein, B. Hypomethylation of Ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 1983, 111, 47–54.
108. Scanlan, M.J.; Gure, A.O.; Jungbluth, A.A.; Old, L.J.; Chen, Y.T. Cancer/testis antigens: An expanding family of targets for cancer immunotherapy. Immunol. Rev. 2002, 188, 22–32.
109. Sincic, N.; Herceg, Z. DNA methylation and cancer: Ghosts and angels above the genes. Curr. Opin. Oncol. 2011, 23, 69–76.
110. Vasanthakumar, A.; Lepore, J.B.; Zegarek, M.H.; Kocherginsky, M.; Singh, M.; Davis, E.M.; Link, P.A.; Anastasi, J.; Le Beau, M.M.; Karpf, A.R.; et al. Dnmt3b is a haploinsufficient tumor suppressor gene in myc-induced lymphomagenesis. Blood 2013, 121, 2059–2063.
111. Van Emburgh, B.O.; Robertson, K.D. Modulation of Dnmt3b function in vitro by interactions with Dnmt3l, Dnmt3a and Dnmt3b splice variants. Nucl. Acids Res. 2011, 39, 4984–5002.
112. Almeida, L.G.; Sakabe, N.J.; de Oliveira, A.R.; Silva, M.C.; Mundstein, A.S.; Cohen, T.; Chen, Y.T.; Chua, R.; Gurung, S.; Gnjatic, S.; et al. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucl. Acids Res. 2009, 37, D816–D819.
113. Hansen, R.S.; Wijmenga, C.; Luo, P.; Stanek, A.M.; Canfield, T.K.; Weemaes, C.M.; Gartler, S.M. The Dnmt3b DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 1999, 96, 14412–14417.
114. Fryns, J.P.; Azou, M.; Jaeken, J.; Eggermont, E.; Pedersen, J.C.; van den Berghe, H. Centromeric instability of chromosomes 1, 9, and 16 associated with combined immunodeficiency. Hum. Genet. 1981, 57, 108–110.
115. Tiepolo, L.; Maraschio, P.; Gimelli, G.; Cuoco, C.; Gargani, G.F.; Romano, C. Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency. Hum. Genet. 1979, 51, 127–137.
116. Ehrlich, M.; Buchanan, K.L.; Tsien, F.; Jiang, G.; Sun, B.; Uicker, W.; Weemaes, C.M.; Smeets, D.; Sperling, K.; Belohradsky, B.H.; et al. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum. Mol. Genet. 2001, 10, 2917–2931.
117. Hagleitner, M.M.; Lankester, A.; Maraschio, P.; Hulten, M.; Fryns, J.P.; Schuetz, C.; Gimelli, G.; Davies, E.G.; Gennery, A.; Belohradsky, B.H.; et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (icf syndrome). J. Med. Genet. 2008, 45, 93–99.
118. Carpenter, N.J.; Filipovich, A.; Blaese, R.M.; Carey, T.L.; Berkel, A.I. Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16. J. Pediatr. 1988, 112, 757–760.
119. Maraschio, P.; Zuffardi, O.; Dalla Fior, T.; Tiepolo, L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: The ICF syndrome. J. Med. Genet. 1988, 25, 173–180.
120. Tuck-Muller, C.M.; Narayan, A.; Tsien, F.; Smeets, D.F.; Sawyer, J.; Fiala, E.S.; Sohn, O.S.; Ehrlich, M. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet. Cell. Genet. 2000, 89, 121–128.
121. Jeanpierre, M.; Turleau, C.; Aurias, A.; Prieur, M.; Ledeist, F.; Fischer, A.; Viegas-Pequignot, E. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum. Mol. Genet. 1993, 2, 731–735.
122. Ji, W.; Hernandez, R.; Zhang, X.Y.; Qu, G.Z.; Frady, A.; Varela, M.; Ehrlich, M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat. Res. 1997, 379, 33–41.
123. Jiang, Y.L.; Rigolet, M.; Bourc’his, D.; Nigon, F.; Bokesoy, I.; Fryns, J.P.; Hulten, M.; Jonveaux, P.; Maraschio, P.; Megarbane, A.; et al. Dnmt3b mutations and DNA methylation defect define two types of ICF syndrome. Hum. Mutat. 2005, 25, 56–63.
124. Wijmenga, C.; Hansen, R.S.; Gimelli, G.; Bjorck, E.J.; Davies, E.G.; Valentine, D.; Belohradsky, B.H.; van Dongen, J.J.; Smeets, D.F.; van den Heuvel, L.P.; et al. Genetic variation in ICF syndrome: Evidence for genetic heterogeneity. Hum. Mutat. 2000, 16, 509–517.
125. Gowher, H.; Jeltsch, A. Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases. J. Biol. Chem. 2002, 277, 20409–20414.
126. Moarefi, A.H.; Chedin, F. ICF syndrome mutations cause a broad spectrum of biochemical defects in Dnmt3b-mediated de novo DNA methylation. J. Mol. Biol. 2011, 409, 758–772.
127. De Greef, J.C.; Wang, J.; Balog, J.; den Dunnen, J.T.; Frants, R.R.; Straasheijm, K.R.; Aytekin, C.; van der Burg, M.; Duprez, L.; Ferster, A.; et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am. J. Hum. Genet. 2011, 88, 796–804.
128. Lee, S.U.; Maeda, T. Pok/zbtb proteins: An emerging family of proteins that regulate lymphoid development and function. Immunol. Rev. 2012, 247, 107–119.
129. Weemaes, C.M.; van Tol, M.J.; Wang, J.; van Ostaijen-Ten Dam, M.M.; van Eggermond, M.C.; Thijssen, P.E.; Aytekin, C.; Brunetti-Pierri, N.; van der Burg, M.; Graham Davies, E.; et al. Heterogeneous clinical presentation in icf syndrome: Correlation with underlying gene defects. Eur. J. Hum. Genet. 2013, 21, 1219–1225.
130. Velasco, G.; Walton, E.L.; Sterlin, D.; Hedouin, S.; Nitta, H.; Yuya, I.; Fouyssac, F.; Megarbane, A.; Sasaki, H.; Picard, C.; et al. Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: Implications for diagnosis and etiology. Orphanet. J. Rare Dis. 2014, 9, 56.
131. Nitta, H.; Unoki, M.; Ichiyanagi, K.; Kosho, T.; Shigemura, T.; Takahashi, H.; Velasco, G.; Francastel, C.; Picard, C.; Kubota, T.; et al. Three novel ZBTB24 mutations identified in japanese and cape verdean type 2 ICF syndrome patients. J. Hum. Genet. 2013, 58, 455–460.
132. Van den Brand, M.; Flucke, U.E.; Bult, P.; Weemaes, C.M.; van Deuren, M. Angiosarcoma in a patient with immunodeficiency, centromeric region instability, facial anomalies (ICF) syndrome. Am. J. Med. Genet. 2011, 155A, 622–625.
133. Narayan, A.; Tuck-Muller, C.; Weissbecker, K.; Smeets, D.; Ehrlich, M. Hypersensitivity to radiation-induced non-apoptotic and apoptotic death in cell lines from patients with the ICF chromosome instability syndrome. Mutat. Res. 2000, 456, 1–15.
134. Wang, J.; Emadali, A.; le Bescont, A.; Callanan, M.; Rousseaux, S.; Khochbin, S. Induced malignant genome reprogramming in somatic cells by testis-specific factors. Biochim. Biophys. Acta. 2011, 1809, 221–225.
135. Rousseaux, S.; Wang, J.; Khochbin, S. Cancer hallmarks sustained by ectopic activations of placenta/male germline genes. Cell. Cycle 2013, 12, 2331–2332.
136. Rousseaux, S.; Debernardi, A.; Jacquiau, B.; Vitte, A.L.; Vesin, A.; Nagy-Mignotte, H.; Moro-Sibilot, D.; Brichon, P.Y.; Lantuejoul, S.; Hainaut, P.; et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci. Transl. Med. 2013, 5, 186ra166.
137. Simpson, A.J.; Caballero, O.L.; Jungbluth, A.; Chen, Y.T.; Old, L.J. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 2005, 5, 615–625.
138. Janic, A.; Mendizabal, L.; Llamazares, S.; Rossell, D.; Gonzalez, C. Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science 2010, 330, 1824–1827.
139. Rudert, F.; Bronner, S.; Garnier, J.M.; Dolle, P. Transcripts from opposite strands of gamma satellite DNA are differentially expressed during mouse development. Mamm. Genome 1995, 6, 76–83.
140. Efroni, S.; Duttagupta, R.; Cheng, J.; Dehghani, H.; Hoeppner, D.J.; Dash, C.; Bazett-Jones, D.P.; le Grice, S.; McKay, R.D.; Buetow, K.H.; et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008, 2, 437–447.
141. Lu, J.; Gilbert, D.M. Proliferation-dependent and cell cycle regulated transcription of mouse pericentric heterochromatin. J. Cell Biol. 2007, 179, 411–421.
142. Eymery, A.; Horard, B.; el Atifi-Borel, M.; Fourel, G.; Berger, F.; Vitte, A.L.; van den Broeck, A.; Brambilla, E.; Fournier, A.; Callanan, M.; et al. A transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells. Nucl. Acids Res. 2009, 37, 6340–6354.
143. Ting, D.T.; Lipson, D.; Paul, S.; Brannigan, B.W.; Akhavanfard, S.; Coffman, E.J.; Contino, G.; Deshpande, V.; Iafrate, A.J.; Letovsky, S.; et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011, 331, 593–596.
144. Alexiadis, V.; Ballestas, M.E.; Sanchez, C.; Winokur, S.; Vedanarayanan, V.; Warren, M.; Ehrlich, M. RNApol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA. Biochim. Biophys. Acta 2007, 1769, 29–40.
145. Enukashvily, N.I.; Donev, R.; Waisertreiger, I.S.; Podgornaya, O.I. Human chromosome 1 satellite 3 DNA is decondensed, demethylated and transcribed in senescent cells and in A431 epithelial carcinoma cells. Cytogenet. Genome Res. 2007, 118, 42–54.
146. Bergmann, J.H.; Jakubsche, J.N.; Martins, N.M.; Kagansky, A.; Nakano, M.; Kimura, H.; Kelly, D.A.; Turner, B.M.; Masumoto, H.; Larionov, V.; et al. Epigenetic engineering: Histone H3K9 acetylation is compatible with kinetochore structure and function. J. Cell Sci. 2012, 125, 411–421.
147. Zhu, Q.; Pao, G.M.; Huynh, A.M.; Suh, H.; Tonnu, N.; Nederlof, P.M.; Gage, F.H.; Verma, I.M. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 2011, 477, 179–184.
148. Jaco, I.; Canela, A.; Vera, E.; Blasco, M.A. Centromere mitotic recombination in mammalian cells. J. Cell Biol. 2008, 181, 885–892.
149. Francastel, C.; Schubeler, D.; Martin, D.I.; Groudine, M. Nuclear compartmentalization and gene activity. Nat. Rev. Mol. Cell Biol. 2000, 1, 137–143.
150. Fisher, A.G.; Merkenschlager, M. Gene silencing, cell fate and nuclear organisation. Curr. Opin. Genet. Dev. 2002, 12, 193–197.
151. Luciani, J.J.; Depetris, D.; Usson, Y.; Metzler-Guillemain, C.; Mignon-Ravix, C.; Mitchell, M.J.; Megarbane, A.; Sarda, P.; Sirma, H.; Moncla, A.; et al. PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J. Cell. Sci. 2006, 119, 2518–2531.
152. Jefferson, A.; Colella, S.; Moralli, D.; Wilson, N.; Yusuf, M.; Gimelli, G.; Ragoussis, J.; Volpi, E.V. Altered intra-nuclear organisation of heterochromatin and genes in ICF syndrome. PLoS One 2010, 5, e11364.
153. Ehrlich, M.; Tsien, F.; Herrera, D.; Blackman, V.; Roggenbuck, J.; Tuck-Muller, C.M. High frequencies of ICF syndrome-like pericentromeric heterochromatin decondensation and breakage in chromosome 1 in a chorionic villus sample. J. Med. Genet. 2001, 38, 882–884.